New gene editing technique CRISPR-Cas9 raises important ethical questions, says advisory body.
BMJ (Clinical research ed.), 354: i5318 PMID 27694221 DOI 10.1136/bmj.i5318
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.